1. Home
  2. ELBM vs RVPH Comparison

ELBM vs RVPH Comparison

Compare ELBM & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELBM
  • RVPH
  • Stock Information
  • Founded
  • ELBM 2011
  • RVPH 2006
  • Country
  • ELBM Canada
  • RVPH United States
  • Employees
  • ELBM N/A
  • RVPH N/A
  • Industry
  • ELBM Industrial Machinery/Components
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELBM Miscellaneous
  • RVPH Health Care
  • Exchange
  • ELBM Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • ELBM 23.2M
  • RVPH 26.6M
  • IPO Year
  • ELBM N/A
  • RVPH N/A
  • Fundamental
  • Price
  • ELBM $1.19
  • RVPH $0.46
  • Analyst Decision
  • ELBM Strong Buy
  • RVPH Strong Buy
  • Analyst Count
  • ELBM 1
  • RVPH 5
  • Target Price
  • ELBM $2.20
  • RVPH $9.00
  • AVG Volume (30 Days)
  • ELBM 122.4K
  • RVPH 2.3M
  • Earning Date
  • ELBM 08-26-2025
  • RVPH 08-22-2025
  • Dividend Yield
  • ELBM N/A
  • RVPH N/A
  • EPS Growth
  • ELBM N/A
  • RVPH N/A
  • EPS
  • ELBM N/A
  • RVPH N/A
  • Revenue
  • ELBM N/A
  • RVPH N/A
  • Revenue This Year
  • ELBM N/A
  • RVPH N/A
  • Revenue Next Year
  • ELBM N/A
  • RVPH N/A
  • P/E Ratio
  • ELBM N/A
  • RVPH N/A
  • Revenue Growth
  • ELBM N/A
  • RVPH N/A
  • 52 Week Low
  • ELBM $0.91
  • RVPH $0.30
  • 52 Week High
  • ELBM $2.83
  • RVPH $4.28
  • Technical
  • Relative Strength Index (RSI)
  • ELBM 50.97
  • RVPH 48.84
  • Support Level
  • ELBM $1.07
  • RVPH $0.40
  • Resistance Level
  • ELBM $1.30
  • RVPH $0.48
  • Average True Range (ATR)
  • ELBM 0.07
  • RVPH 0.04
  • MACD
  • ELBM -0.00
  • RVPH 0.01
  • Stochastic Oscillator
  • ELBM 47.92
  • RVPH 46.15

About ELBM Electra Battery Materials Corporation

Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: